YS Chen, SF Hackett, CL Schoenfeld, MA … - British Journal of Ophthalmology, 1997 - bjo.bmj.com AIMS/BACKGROUND Epiretinal membranes (ERMs) arise from a variety of causes or,
in some cases, for unknown reasons. Once established, ERMs tend to progress,
becoming more extensive and exerting increasing traction along the inner ... Cited by 56 - Related articles - BL Direct - All 8 versions
SA Schneeberger, LM Hjelmeland, RP Tucker … - American journal of ophthalmology, 1997 - cat.inist.fr . PURPOSE: To determine by immunocytochemical analysis of epiretinal membranes
whether vascular endothelial growth factor and the fibroblast growth factor
FGF-5 are present in patients with proliferative diabetic retinopathy or ... Cited by 24 - Related articles - All 2 versions
M Guerrin, H Moukadiri, P Chollet, F Moro, K … - Journal of cellular physiology, 1995 - interscience.wiley.com Vasculotropin (VAS), also called vascular endothelial growth factor (VEGF) or
vascular permeability factor, is a secreted growth factor whose target cell
specificity has been reported as restricted to vascular endothelium. Its ... Cited by 104 - Related articles - BL Direct - All 3 versions
D Armstrong, AJ Augustin, R Spengler, A Al- … - Ophthalmologica, 2000 - content.karger.com Drug Dosage: The authors and the publisher have exerted every effort to ensure
that drug selection and dosage set forth in this text are in accord with current
recommendations and practice at the time of publication. However, in view ... Cited by 71 - Related articles - BL Direct - All 5 versions
SA Vinores, JD Henderer, J Mahlow, C Chiu, … - Experimental eye research, 1995 - Elsevier Epiretinal membranes (ERMs) form on the inner surface of the retina in
conjunction with various ocular disease processes, but the factors controlling
their development are not understood. The predominant cell types involved ... Cited by 42 - Related articles - BL Direct - All 3 versions
SG Robbins, RN Mixon, DJ Wilson, CE Hart, … - Investigative ophthalmology & visual science, 1994 - ncbi.nlm.nih.gov PURPOSE. Platelet-derived growth factor (PDGF) and its receptors could
contribute to the development of proliferative retinal membranes, because PDGF
is angiogenic and is both mitogenic and chemotactic for retinal pigment ... Cited by 96 - Related articles - BL Direct - All 2 versions
- ►iovs.org Y Ikuno, FL Leong, A Kazlauskas - Investigative ophthalmology & visual science, 2002 - ARVO PURPOSE. It has been reported that the platelet-derived growth factor (PDGF)-
receptor ( PDGFR) is required for experimental proliferative vitreoretinopathy
(PVR) in rabbits. This study investigated which of the signaling enzymes ... Cited by 14 - Related articles - BL Direct - All 3 versions
- ►iovs.org A Andrews, E Balciunaite, FL Leong, M … - Investigative ophthalmology & visual science, 1999 - ARVO PURPOSE. The action of growth factors is thought to make a substantial
contribution to the events leading to proliferative vitreoretinopathy (PVR). In
this study, the importance of platelet-derived growth factor (PDGF) was ... Cited by 68 - Related articles - BL Direct - All 4 versions
M Wada, N Ogata, T Otsuji, M Uyama - Current Eye Research, 1999 - informahealthcare.com Page 1. VEGF and KDR expression in choroidal neovascularization 203 Expression
of vascular endothelial growth factor and its receptor ... Cited by 77 - Related articles - BL Direct - All 6 versions
